TCRX tscan.com: Sof marja

Ommaviy kompaniya tscan.com (TCRX) logotipi

TScan Therapeutics (TCRX) qattiq o'smalarga qarshi kurashish uchun shaxsiylashtirilgan T-hujayra texnologiyalarini tijoratlashtirishga tayanadi. Konsolidatsiyalashgan sof savdo marjasi biznesning operatsion barqarorligini namoyish etadi va -2219.20 qiymati ushbu ko'rsatkichni aks ettiradi. Yuqori biomanufakturing xarajatlari va qat'iy tartibga soluvchi nazorat bozorni cheklaydi, அதே vaqtda ulkan R&D xarajatlari FDA filtrlarining kombinatsiyasi raqobatchilar uchun yengib bo'lmas to'siqlarni yaratadi.

TCRX: TScan Therapeutics Inc Sof foyda normasi 04.07.2022 - 19.11.2026

tscan.com (TCRX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning har tomonlama tahlili:TScan Therapeutics
TScan Therapeutics yetakchi tovari

Sof foyda marjasi sof foydaning umumiy daromadga nisbati sifatida hisoblanadi va xarajatlarni boshqarish samaradorligini o'lchaydi. Ushbu ko'rsatkich barcha operatsion va moliyaviy xarajatlar qoplanganidan keyin daromadning har bir dollari qancha qolishini belgilaydi. TScan Therapeutics (TCRX) uchun ushbu metrika TCR-T terapiyalarini ishlab chiqishning kapital intensivligini va IT platformasini tasdiqlash xarajatlarini aks ettiradi. Sof foyda marjasini tahlil qilish joriy klinik sinov xarajatlarini uzoq muddatli moliyaviy maqsadlar bilan solishtirish imkonini beradi. Ushbu grafikdagi narx harakati hisobotlardagi kechikishlarni bartaraf etib, kapitalning real vaqt rejimida sarflanish sur'atini ochib beradi.

TScan Therapeutics kimlar bilan raqobatlashadi

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)